Treace Medical Concepts, Inc.
TMCI- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- SEC CIK
- 0001630627
In the last 90 days, Treace Medical Concepts, Inc. insiders filed 1 open-market purchase and 0 sales; 116 institutions reported holding it in 13F filings for Q2 2026, worth $126.8M in total; no superinvestor holds it.
Q4 2024 vs. Q3 2024
How the institutions holding Treace Medical Concepts, Inc. changed between Q3 2024 and Q4 2024.
All holders in Q4 2024All holders in Q3 2024
| Measure | Q3 2024 | Of which not filed for Q4 2024 | Q4 2024 | Change |
|---|---|---|---|---|
| Holders | 134 | 1 | 135 | +2 |
| Shares | 39.6M | 3.00K | 37.3M | −2.32M (−5.9%) |
| Value | $229.8M | $17.4K | $277.8M | +$48.0M (+20.9%) |
1 institution that held it in Q3 2024 haven't filed for Q4 2024 yet. Not filing isn't selling, so the changes leave them out.
New holders (25)
Institutions that held Treace Medical Concepts, Inc. at the end of Q4 2024 but not at the end of Q3 2024.
Sold out (23)
Institutions that held Treace Medical Concepts, Inc. at the end of Q3 2024 and filed for Q4 2024 without it.
| Institution | Shares, Q3 2024 | Value, Q3 2024 |
|---|---|---|
| Soleus Capital Management, L.P. | 887,941 | $5.15M |
| Algert Global LLC | 150,991 | $875.7K |
| Gsa Capital Partners LLP | 149,129 | $865.0K |
| UBS Asset Management Americas Inc | 126,761 | $735.2K |
| Twinbeech Capital LP | 114,531 | $664.3K |
| Divisadero Street Capital Management, LP | 114,400 | $663.5K |
| Swiss National Bank | 84,700 | $491.3K |
| Virtu Financial LLC | 25,572 | $148.0K |
| EntryPoint Capital, LLC | 24,788 | $143.8K |
| Janus Henderson Group PLC | 19,553 | $113.3K |
| Stoneridge Investment Partners LLC | 16,852 | $98.0K |
| Zurcher Kantonalbank (Zurich Cantonalbank) | 16,685 | $96.8K |
| Brinker Capital Investments, LLC | 13,853 | $80.3K |
| Orion Portfolio Solutions, LLC | 13,853 | $80.3K |
| Wolverine Trading, LLC | 12,946 | $74.7K |
| Arizona State Retirement System | 12,499 | $72.5K |
| Savant Capital, LLC | 11,102 | $64.4K |
| Graham Capital Management, L.P. | 10,336 | $59.9K |
| HighTower Advisors, LLC | 10,003 | $58.0K |
| VisionPoint Advisory Group, LLC | 5,347 | $31.0K |
| National Bank of Canada | 593 | $3.44K |
| Smartleaf Asset Management LLC | 108 | $623 |
| Capital Performance Advisors LLP | 1 | $6 |
Not filed for Q4 2024 yet (1)
Institutions that held Treace Medical Concepts, Inc. at the end of Q3 2024 and haven't filed a 13F for Q4 2024. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q3 2024 | Value, Q3 2024 |
|---|---|---|
| Planning Capital Management Corp | 3,000 | $17.4K |